Cheng-yuan Gu

Key Laboratory Of Thrombosis And Hemostasis Of Ministry Of Health, State Key Laboratory Of Radiation Medicine And Protection
Suzhou, 215006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

PD-1 Inhibitor Combined with Azacitidine and HAG Regimen for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia: A Prospective, Single-Arm, Phase II Clinical Study

PD-1 Inhibitor Combined with Azacitidine and HAG Regimen for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia: A Prospective, Single-Arm, Phase II Clinical Study

Journal: Zhongguo shi yan xue ye xue za zhi

Published: September 11, 2025

Real-world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag.

Real-world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag.

Journal: British journal of haematology

Published: April 07, 2024

The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation.

The expression and prognostic value of transporter 1, ATP binding cassette subfamily B member in clear cell renal cell cancer with experimental validation.

Journal: Frontiers in oncology

Published: August 07, 2022

The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.

The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.

Journal: Molecular medicine (Cambridge, Mass.)

Published: February 11, 2022

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation.

Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation.

Journal: Frontiers in oncology

Published: August 22, 2021

Genetic variants in RTEL1 influencing telomere length are associated with prostate cancer risk.

Genetic variants in RTEL1 influencing telomere length are associated with prostate cancer risk.

Journal: Journal of Cancer

Published: April 20, 2019

Clinical significance of urine prostatic exosomal protein in the diagnosis of prostate cancer.

Clinical significance of urine prostatic exosomal protein in the diagnosis of prostate cancer.

Journal: American journal of cancer research

Published: February 21, 2019

A single nucleotide polymorphism in CYP1B1 leads to differential prostate cancer risk and telomere length.

A single nucleotide polymorphism in CYP1B1 leads to differential prostate cancer risk and telomere length.

Journal: Journal of Cancer

Published: July 05, 2017

Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.

Genetic variants of the CYP1B1 gene as predictors of biochemical recurrence after radical prostatectomy in localized prostate cancer patients.

Journal: Medicine

Published: July 12, 2016

MTHFR c.677C>T Inhibits Cell Proliferation and Decreases Prostate Cancer Susceptibility in the Han Chinese Population in Shanghai.

MTHFR c.677C>T Inhibits Cell Proliferation and Decreases Prostate Cancer Susceptibility in the Han Chinese Population in Shanghai.

Journal: Scientific reports

Published: June 28, 2016

Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population.

Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population.

Journal: Scientific reports

Published: June 03, 2016

The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy.

The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy.

Journal: Asian journal of andrology

Published: February 06, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026